Clinical trial
"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"
NCT04641780 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical, Inc., Philippines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"
- Lead sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 17, 2019
- Completion date
- March 31, 2024
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.